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Introduction {#s1}
============

Little is known about why the effects of environmental agents, including industrial chemicals, manufacturing by-products, metals, pesticides, and herbicides differ between individuals within and across populations ([@c1]; [@c58]; [@c8]). There is strong evidence that gene--environment interactions (GxE) play an important role in health outcomes, and that these interactions are likely a major source of the heterogeneity in chemical response. It is well established that GxE are an important component of the etiology of complex traits and diseases ([@c22]). Pharmacogenomic studies have consistently demonstrated that differential susceptibility to chemical exposure is directly related to genetic variation ([@c23]; [@c36]). Thus, for any genetically diverse population, latent genetic variation may contribute to observed differential susceptibility when challenged by chemical exposure. While it is accepted that such GxE interactions are important, there remain significant challenges---both experimental and statistical---in detecting and characterizing such interactions ([@c42]; [@c53]).

The zebrafish (*Danio rerio*), with over 26,000 protein-coding genes consisting of orthologues for over 70% of human genes, has gained momentum as a model organism in vertebrate genomics ([@c21]; [@c33]). Toxicological and pharmacological applications in chemical biology have also seized upon the many benefits of zebrafish, including the short generation time, well-characterized development, and early maturation as clear embryos ([@c26]). Various morphological end points are easy to observe, and effects of multiple chemical exposures on these outcomes have been broadly studied ([@c3]; [@c5]; [@c47]; [@c50]). These advantages have led to an upward trend in high-throughput zebrafish chemical screens, especially toward screens of many chemicals in many fish, primarily in 96-well plates ([@c44]). Thus, there exists potential for large-scale studies of chemical bioactivity that integrate genetic information to probe mechanisms underlying morphologic response to chemical exposures during development ([@c4]) or even across multiple generations ([@c27]; [@c28]).

Zebrafish populations differ from many model organisms in that the standard husbandry practices can be designed to maintain diversity ([@c37]), meaning that most laboratory populations contain an unknown level of genetic diversity ([@c10]). While this diversity is attractive in translating to questions of human and ecological health, it raises critical questions of how unmeasured interindividual genetic variation might contribute to susceptibility differences in response to chemical exposure. Uncharacterized genetic diversity can manifest as apparent error effects within and across laboratories ([@c44]).

Comparisons between named strains and interlab populations of zebrafish have shown variability in several phenotypes, providing the rationale that constitutive genetic variation may contribute to the variability in exposure response ([@c30]). Unfortunately, partitioning this variability among genetic, environmental, and phenotypic factors is hindered by (non)systematic differences in experimentation, statistical analysis, and most importantly, by a lack of available genetic data for the strains evaluated. Despite the small samples (one to two individual fish) or pooled strategies used in studies aiming to characterize genetic diversity, results have shown between 5 and 15 million single-nucleotide polymorphisms (SNPs) segregating in a zebrafish population, with roughly half of the variants showing evidence of population specificity ([@c11]; [@c29]; [@c38]; [@c40]).

To address these limitations, we directly interrogated GxE interactions by individually sequencing entire genomes from a large sample of zebrafish using refined experimental and statistical methods for characterizing phenotypic responses to chemical exposure ([@c18]; [@c48]; [@c54], [@c55]). The analytical methods were developed using years of data from high-throughput studies HTS of diverse chemicals in the Tanguay Laboratory's (Oregon State University, Corvallis, OR) Tropical 5D Zebrafish line (T5D). The T5D line is an outbred population of heretofore unknown genetic heterogeneity that has been used to screen thousands of chemicals for adverse biological responses ([@c43]; [@c47]). We leveraged these HTS data to identify a chemical (Abamectin) that elicited biological response patterns indicative of population genetic differences, and then generated genome-wide sequence data to compare individuals displaying differential susceptibility to chemical exposure. To our knowledge, this is the first genome-wide association study (GWAS) using individually sequenced zebrafish drawn from a diverse population. Our approach inverts the paradigm of typical GxE research, where rather than interrogating the same list of usual chemical suspects, we only ask questions of particular compounds that have strong evidentiary support for differential population susceptibility.

Methods {#s2}
=======

Overview of Experimental Approach {#s2.1}
---------------------------------

First, we exploited the large-scale design of a high-throughput screening (HTS) system that has tested thousands of chemicals in an outbred zebrafish population of unknown genetic heterogeneity to select Abamectin as a chemical that displayed phenotypic patterns of high variability between individual responses. Second, we characterized the correlation structure across morphological end points in order to describe a specific multivariate Affected vs. Unaffected phenotype in zebrafish exposed to Abamectin. Third, we performed range-finding studies to narrow our estimate of the Abamectin critical concentration to that at which a stable 50:50 Affected:Unaffected proportion was observed. Fourth, samples were exposed to the critical concentration of Abamectin, from which we isolated DNA from Affected samples that displayed our multivariate phenotype and Unaffected samples that did not respond to chemical exposure. Fifth, whole-genome sequences were generated from DNA individually isolated from each Affected and Unaffected sample. These data were then used to identify GxE as genetic variants associated with differential response to chemical exposure.

Experimental Population and Developmental Screening System {#s2.2}
----------------------------------------------------------

Adult T5D (wildtype) zebrafish were housed at Sinnhuber Aquatic Research Laboratory at Oregon State University. All experiments in this manuscript used this population, which originated from a minimum of 25 small group crosses, each group containing three males and three females. Each generation was propagated using equal proportions of offspring from the original group crosses. Adult zebrafish were group spawned to produce embryos for the developmental screening system detailed in Truong et al. ([@c47]). In this system, embryos were dechorionated ([@c49]) and placed into individual wells of a 96-well plate. Chemical exposures were initiated at 6 hpf and evaluated at 120 hpf (hours post fertilization) for 17 morbidity and mortality end points. The end points evaluated were MORT: mortality at 120 hpf, YSE: yolk sac edema, AXIS: bent body axis, EYE: eye, SNOU: snout, JAW: jaw, OTIC: otic, PE: pericardial edema, BRAI: brain, SOMI: somite, PFIN: pectoral fin, CFIN: caudal fin, CIRC: circulation, PIG: pigmentation, TRUN: trunk length, SWIM: swim bladder, and NC: notochord distortion. Each end point was recorded as present or absent for each individual embryo. These binary vectors of 17 morphological end points per individual were used for subsequent analysis.

Identifying Chemicals with Evidence of Differential Population Response {#s2.3}
-----------------------------------------------------------------------

Screening data on 1,060 chemicals from Truong et al. ([@c47]) were evaluated to prioritize chemicals for GWAS mapping. Our aim was to identify the chemical with maximal evidence of differential response for optimal GxE power. Chemical choice was based on morphological data from a large-scale, concentration--response study of chemically exposed zebrafish embryos assessed for developmental toxicity end points at 120 hpf. In searching for patterns indicative of population variability over a broad, multipoint concentration series, our prioritization metric highlighted maximal population variability in response across all binary morphological end points to identical environmental exposures. The full concentration--response data for 1,060 chemicals ($n = 32$ samples tested across each of five chemical concentrations) were analyzed. We first produced a sublist of chemicals that had at least one morphological end point (other than mortality) observed at near 50% incidence (32--68%) at a minimum of two concentrations. This measure ensured that there was developmental variability between fish exposed to that chemical (i.e., high proportions of both Affected and Unaffected individuals), that a stable critical concentration could be estimated, and that the response variability held for more than one concentration. Given our goal of maximizing interindividual response variability, the latter principle ensured a less steep concentration--response curve and a higher probability that reproducible patterns of differential population response to exposure would be observed in subsequent trials.

Generating Data at a Critical Exposure Concentration to Elicit Maximal Population Variability {#s2.4}
---------------------------------------------------------------------------------------------

Two rounds of range-finding experiments were performed to estimate a critical concentration of test chemical (Abamectin, CASRN 71751-41-2, Sigma-Aldrich) that induced 50% incidence of effect so that the genetic association study could draw evenly from Affected and Unaffected individuals. For each round, adult zebrafish were group spawned to produce embryos that were exposed to several concentrations of Abamectin, following the developmental screening protocol detailed above. First, 576 individual zebrafish embryos were distributed into six 96-well plates, with 12 individuals per plate exposed to a concentration (0, 0.03, 0.1, 0.3, 1, 3, 5, or $10\;\mu M$) using a $20\text{-mM}$ stock of Abamectin digitally dispensed using an HP D300e (Hewlitt Packard HP D300e). Second, a narrower range including 0, 0.5, 0.7, and $0.9\;\mu M$ was performed using 192 individuals (48 per concentration). From these data, the final critical concentration of $0.6\;\mu M$ was selected to approximate a 50% effect size while ensuring sufficient numbers of completely clean (i.e., absence of adverse developmental end points) Unaffected samples.

After the concentration was established, individual zebrafish were exposed to the critical concentration of $0.6\;\mu M$ of Abamectin to identify individuals responding differently to equivalent environmental concentrations. We also included untreated (negative) controls on each plate (Exposed: control ratio at 72:24 per plate) to ensure that we could detect global plate effects and have confirmatory samples to sequence if unexpected genotype distributions had been encountered. The total number of samples exposed was 768 (8 plates with 96 individuals), including 576 Exposed:192 Control. From the exposed embryos and knowledge of end point--end point relationships and developmental cascades ([@c54], [@c55]), we identified samples of maximum phenotypic clarity (i.e., no intermediates) to define a clean multivariate phenotype of individuals Affected by exposure vs. individuals Unaffected by the same Abamectin exposure. For Affected status, an individual had to display all of the following specific end points: altered eye, snout, jaw, and axis development, plus pericardial and yolk sac edema (EYE, SNOU, JAW, AXIS, PE, and YSE). The Unaffected phenotypic status was applied to individual embryos having absence of any morphological defect (i.e., normally developed embryos). A total of 276 (138 Affected, 138 Unaffected) zebrafish exposed at the critical concentration were randomly selected to be sequenced for genome-wide association mapping. While other individuals may have been classifiable into one of our two extreme, Affected/Unaffected classes, we optimized sequencing resources towards fully penetrant phenotypes in order to maximize discriminatory power.

Genotyping by Sequencing {#s2.5}
------------------------

Genomic DNA was extracted from individual larvae (Quick-DNA™ 96-Kit, Cat \# D3011; Zymo Research), with a subset selected for sequencing. For each sample, $350\,\text{ng}$ of DNA was used for library preparation. Prior to library prep, the quality and quantity was verified using a fluorometric plate reader and bioanalyzer. Samples were sheared to $\sim 320\,\text{base}\,\text{pair}\,\left( \text{bp} \right)$, and $100\,\text{ng}$ of each sample was used in the WaferGen DNA amplification library prep kit (Takara Bio, USA). After the library prep, each sample was quantified to verify similar input for sequencing. The samples were sequenced on an HiSeq3000 (Illumina) with 12 samples per lane ($\sim \text{five}\,\text{times}$ coverage) and 150-bp paired-end sequencing. All library preparation and sequencing was performed at Oregon State University's Center for Genome Research and Biocomputing (<http://cgrb.oregonstate.edu/core>).

Quality Control and Alignment {#s2.6}
-----------------------------

FastQC (Babraham Bioinformatics version 0.11.3) tests for sequence quality, Guanine Cytosine (GC) content, sequence length distribution, sequence duplication levels, overrepresented sequences, adaptor content, and kmer content were used to ensure fidelity of results. For each sample (DNA from an individual zebrafish), reads were aligned to the Genome Reference Consortium GRCz10 ([@c21]) reference genome with Bowtie2 (version 2.1.0; open source) ([@c31]), using standard settings. Potential PCR duplicates were then removed using Samtools rmdup ([@c32]).

Variant Calling and Filtering {#s2.7}
-----------------------------

Variant calls were generated for each individual at every variant site. A variant call was made at any site (across the entire genome, including all chromosomes and mitochondrial DNA, excluding nonchromosomal material or scaffolds not aligned within a chromosome) where there was sufficient evidence of a nonreference base for at least one individual. GATK version 3.5 ([@c34]) HaplotypeCaller was used to call genotypes on all samples simultaneously (joint genotyping). This leverages data across samples to assign genotypes for individuals with low coverage at certain bases using a Bayesian likelihood model for genotyping. Reads with a mapping quality (MQ) below 20 were not included, and a minimum phred-scaled confidence threshold of 10 was required. Genotypes are reported for every individual at every variant site for which there remained reads.

The GATK VariantFiltration tool was used to implement the GATK Best Practices ([@c16]) hard filtering recommendations (filter SNPs with quality by depth $< 2$; phred-scaled Fisher's exact test *p*-value $> 60$; root mean score MQ $< 35$; MQ Mann-Whitney rank sum $< - 12.5$; read position Mann-Whitney rank sum $< - 8$; strand odds ratio $> 3$). The MQ threshold of 35 was adjusted from GATK's recommendation of 40. This is due to the GATK workflow's use of a different aligner, which outputs a larger range of MQ scores for each base, averaging 60 for high confidence reads. The maximum MQ outputted from the Bowtie2 aligner is only 42 (for a perfectly aligned read with no mismatches to the reference). A final filtering refinement and file conversion for subsequent analysis was performed using VCFtools \[VCFtools version 0.1.14 ([@c15])\]. SNPs with mean depth (across samples) below 2 were excluded. This was done to reduce false-positive calls for SNPs that were based on too few reads per individual.

Association Analysis {#s2.8}
--------------------

An allelic association analysis (Fisher's exact tests) was run for each SNP across the genome using PLINK 1.9 ([@c41]). For each SNP, the counts of the minor and major alleles in the cases (morphologically Affected individuals) and controls (morphologically Unaffected individuals) were used to calculate the exact hypergeometric probability of observing those four counts under the null hypothesis that allele counts in cases and control do not differ. A *p*-value below $\alpha = 0.05$ provides sufficient evidence that the allele counts for each group do statistically differ. To adjust for multiple testing, a Bonferroni correction was used, leading to a significant call for any SNP with a $p\text{-value} < 2.55 \times 10^{- 9}$ (0.05/19,597,672).

Validation {#s2.9}
----------

For validation of candidate SNPs identified in our GWAS, gene expression was measured following Abamectin exposure on a new set of individuals that were randomly sampled from the population. The developmental screening protocol was identical to that described earlier. At 120 hpf, 84 individuals (balanced between control, Affected, and Unaffected) were randomly selected for real-time polymerase chain reaction (RT-PCR) gene expression analysis. Embryos from wells of interest (Affected and Unaffected) were independently snap frozen using liquid nitrogen and then copurified for RNA and DNA using ZR-Duet™ MiniPrep (Cat \#D7001; Zymo Research). A list of the forward and reverse primers (targeting a SNP just upstream of *sox7*, which had the smallest GWAS *p*-value) used for the experiment can be found in Table S1 (Integrated DNA Technologies). The mRNA gene expression analysis was performed as described in Chlebowski et al. ([@c13]).

Expression of target gene *sox7* and housekeeping gene *beta actin* were measured as threshold cycle ($C_{T}$) value using relative standard curves to optimize how much input was in the reaction. Prior to analysis of RT-PCR results, one control individual was discarded for an abnormally high $C_{T}$ value ($C_{T} > 32$; for other samples, $27 < C_{T} < 30$), and six individuals (two Affected; four Unaffected) were discarded due to insufficient amplification signal. A two-sample *t*-test was first conducted to ensure that *beta actin* was not differentially expressed in control individuals compared to exposed (Affected and Unaffected) individuals ($p = 0.58$). The statistical analysis of *sox7* expression was then based on the $\log_{2}$ fold change calculated for each individual using the ${\Delta\Delta}C_{T}$ method: $$\Delta C_{T}\left( i \right) = sox7\, C_{T}\left( i \right) - beta\, actin\, C_{T}\left( i \right)$$$${\Delta\Delta}C_{T}\left( i \right) = \Delta C_{T}\left( i \right) - \sum\limits_{j = 1}^{c}\frac{\Delta C_{T}\left( j \right)}{c}$$$$Fold\, Change\left( i \right) = 2^{- {\Delta\Delta}C_{T}{(i)}}$$

Individual *i* is one of the total number of control, Affected, and Unaffected individuals, and *c* is the number of control individuals. The fold change for each individual is with respect to the average control. A two-sample *t*-test was then conducted comparing $\log_{2}$ (fold change) for Affected vs. Unaffected individuals.

Results {#s3}
=======

Response Patterns Indicative of Differential Susceptibility {#s3.1}
-----------------------------------------------------------

We exploited the HTS data from Truong et al. ([@c47]) to identify chemicals with empirical evidence of population susceptibility differences, as illustrated in [Figure 1A](#f1){ref-type="fig"}. Out of 1,060 chemicals screened in full concentration--response by [@c47], there were 19 that met our population variability heuristic (Table S2). From this empirical shortlist, Abamectin had the most robustly variable response (i.e., highest proportion of responders) across the most concentrations. Given the broad concentration spacing ($\log_{10}$) of the HTS design, certain individuals (Unaffected) tolerated concentrations of Abamectin that were orders of magnitude higher than concentrations causing severe abnormalities in other individuals (Affected).

![Study Design. (*A*) Chemical selection from HTS data: Example concentration--response curves from 1,060 chemicals interrogated for adverse morphological end points. Each panel represents a test chemical where the proportion of individuals displaying adverse morphological development (vertical axis) is plotted against the tested concentrations (horizontal axis). The curve with the asterisk in the upper left-hand corner of the panel represents a chemical response suggestive of differential population susceptibility, whereas all other curves depict steeper toxic points of departure (i.e., less spread in the range of concentrations eliciting effects across the population) or lack of response. (*B*) Rangefinders: Successive screens to find the critical concentration as that at which approximately 50% incidence is observed. The heatmaps show horizontal blocks (separated by whitespace) of identical concentrations, whose height corresponds to the number of zebrafish tested. Within each concentration block, each row is the vector of observed morphological end points (17 columns; see "Methods" section) for an individual. As per the legend at the lower right, blue represents no end point incidence, red represents incidence of an end point, and grey cross-hatching represents mortality. (*C*) Critical concentration exposure: Example of a single exposure plate, where 72 individuals (in single wells) were exposed to $0.6\;\mu M$ Abamectin at 6 hpf, plus 24 individuals exposed to vehicle \[dimethylsulfoxide (DMSO)\] controls. Developmental morphology screening was performed at 120 hpf to identify Affected individuals with the phenotype of altered eye (EYE), snout (SNOU), jaw (JAW), pericardial edema (PE), yolk sac edema (YSE), and axis development (AXIS) vs. Unaffected individuals with no observed defects. (*D*) Individual DNA extraction: Individuals classified as Affected and Unaffected were randomly selected for whole-genome sequencing.](EHP2662_f1){#f1}

Rangefinder Experiments to Pinpoint a Critical Concentration {#s3.2}
------------------------------------------------------------

[Figure 1B](#f1){ref-type="fig"} illustrates the progression of rangefinder experiments aimed at identifying the critical concentration for morphological effects induced by Abamectin. Power estimates showed that in the absence of prior knowledge of allele frequencies or population genetic structure, the optimal study design should include a balanced phenotypic ratio of Affected:Unaffected samples. Therefore, rangefinders aimed to find the concentration eliciting an even ratio of our complete phenotype. The first round narrowed the variable--response concentrations of the original HTS data to a range between $100\,\text{ng}$. The second round tightened the target range between $0.03–10\;\mu M$. From these data, $0.6\;\mu M$ was chosen as the critical concentration as intermediate between the high incidence at $0.7\;\mu M$ and the low incidence at $0.5\;\mu M$.

Identifying Individuals for Genomic Sequencing {#s3.3}
----------------------------------------------

Of the 576 fish exposed to Abamectin at the critical concentration, we observed 3% mortality at the 120 hpf evaluation. Of the surviving exposed fish, 155 (28%) displayed the fully penetrant Affected phenotype (see [Figure 1C](#f1){ref-type="fig"}, image of Affected individual with arrows pointing to specific end points), 200 fish (36%) were Unaffected, and the remainder of surviving individuals were scored as having an intermediate phenotype that consisted of a subset of the full Affected end point set. This is evidence of population variability in response to chemical exposure. From the fish at the two phenotypic extremes, 276 individuals were randomly chosen for full-genome sequencing (138 Affected and 138 Unaffected). By first focusing on a clean Affected group of fish that scored exactly the same on the morphologic measures, we reduced potential variability coming from sources other than genetics and thereby increased the power to detect association. In unexposed control individuals, only 1% showed any specific morphological deformity (none of whom showed the specific phenotype of interest), vs. 65% of exposed individuals ($p < 10^{- 16}$).

Genetic Polymorphisms Associated with Gene-by-Environment {#s3.4}
---------------------------------------------------------

FastQC output indicated that reads were 151 bp in length. The overall alignment rate was 89% for each sample. GC content for each sample was approximately 37%, which is consistent with the zebrafish genome ([@c19]). All individual samples passed QC and were retained. Before base quality control/filtration, there were 44,150,378 variant sites (36,532,474 SNPs) with an average of 4.2 times coverage per site. After applying filtering cutoffs, 19,973,683 SNPs remained. The final VCFtools filter left 19,597,672 SNPs for association analysis.

Association analysis was conducted for each SNP across the genome using Fisher's exact test in PLINK 1.9 ([@c41]) to assess allele counts in the Affected vs. Unaffected individuals. To adjust for multiple testing, we subjected our nominal *p*-value ($\alpha = 0.05$) to a Bonferroni correction of (0.05/19,597,672), yielding a genome-wide significance threshold of $p < 2.55 \times 10^{- 9}$. The strict statistical significance criteria highlighted three SNPs that exceeded the genome-wide significance thresholds ([Figure 2](#f2){ref-type="fig"} and Table S3). The SNPs (ranked in order of ascending *p*-value) were mapped to genic regions of *sox7*, *erf*, and *cfap74*.

![Genome-wide association study (GWAS) results for Abamectin. The Manhattan plot shows the genomic coordinate for each SNP on the horizontal axis (grouped into chromosomes) vs. its association with phenotypic status on the vertical axis (as the negative logarithm of *p*-value). The horizontal line indicates the Bonferroni-adjusted significance threshold. The dots above this line indicate candidate SNPs (*cfap* on chromosome 8, *erf* on chromosome 19, *sox7* on chromosome 20) for validation as genetic factors associated with differential susceptibility (i.e., Affected vs. Unaffected phenotypes) to Abamectin exposure.](EHP2662_f2){#f2}

Validation {#s3.5}
----------

From the genome-wide data, a $\left. G\rightarrow T \right.$ variant in the promoter region (569 bp upstream) of *sox7* (the top hit in [Figure 2](#f2){ref-type="fig"}) was significantly associated with severe developmental end points after exposure. This SNP had the smallest *p*-value and was observed at high prevalence in the population tested, highlighting a promising target for functional validation. The SNP region upstream of *sox7* and expression primer design for the validation study are highlighted in [Figure 3A and Table S1](#f1 f3){ref-type="fig"}. The lower portion of [Figure 3A](#f3){ref-type="fig"} shows the T allele frequency differences at this SNP between Affected (45%) and Unaffected (12%) individuals. In the validation study, using a new sample of individuals from the population, *sox7* showed significantly lower expression ($p = 0.02$; [Figure 3B](#f3){ref-type="fig"}) at 120 hpf for Affected ($n = 26$) vs. Unaffected individuals ($n = 24$) after exposure to $0.6\;\mu M$ Abamectin.

![Functional Validation of *sox7*. (*A*) Depiction of the *sox7* transcript, gene expression primer locations, and frequency sequence logos for the region surrounding the significant SNP (20:19,166,444) in Affected and Unaffected individuals from the genome-wide association study (GWAS). Sequence logos are centered at the SNP site, denoted as position 0. The relative letter height corresponds to the frequency of the base at that position. (*B*) Notched boxplots showing the distribution of $\log_{2}$ (fold change) of *sox7* expression for Control (unexposed), Unaffected (exposed), and Affected (exposed) groups. The boxplots show the median (thick horizontal lines), the upper and lower quartiles (top and bottom of boxes, respectively), 1.5 times the interquartile range (whiskers), and any outlier samples outside the whisker range of the observed expression for each group.](EHP2662_f3){#f3}

Discussion {#s4}
==========

Our evidence from Abamectin-exposed zebrafish showed that interindividual (i.e., population) genetic variation contributes to differential response to environmental chemical exposures. To reach this conclusion, we first exploited the large-scale, systematic design of HTS data ([@c47]) to select a target chemical (Abamectin) whose exposure produced patterns of differential response in the exposed population. Next, we generated genome-wide sequence data for individual zebrafish displaying susceptible vs. resistant phenotypes following identical chemical exposure. Finally, we identified a genetic region near *sox7* associated with this GxE effect and confirmed gene expression differences between susceptibility groups.

This approach addresses a critical need in the face of an expanding chemical exposome ([@c52]). Select individuals or entire communities may be especially susceptible to adverse health effects from chemical exposure through common consumer products, occupational hazards, environmental emergencies, or geographic location, such as Superfund sites ([@c46]; [@c9]; [@c24]). Models for diverse populations are needed to explore this interindividual susceptibility ([@c17]). The T5D zebrafish line used in our experiments presents such a genetically heterogeneous population, containing levels of interindividual diversity required for studies of differential susceptibility ([@c6]).

In contrast to the pooled samples commonly used for these types of experiments in zebrafish ([@c11]; [@c38]), we followed individuals (in single-fish wells) from immediately postfertilization throughout the entire environmental exposure course, all phenotypic assessments, and generation of genetic information. Analysis of individual-level differences in behavioral and morphological responses to chemicals provided solid phenotypic anchors for genetic results. Indeed, our results demonstrated reproducible population variability in a multivariate phenotype that showed consistent concentration--response to chemical treatment across successive rounds of narrowing concentration. The fine-scale quantification of phenotype and exposure environment enabled us to elucidate the role that genetic variation can play in differential susceptibility. This specificity, where we can identify individual-level genetic variation that affects response to individual chemical environments, may bring new precision to personalized toxicity prediction and risk assessment.

Importantly, the authors note that the test compound, Abamectin, is not a genotoxic compound that would have been expected to alter DNA sequence ([@c39]). Abamectin is a standard compound formulation of avermectin B1a and B1b and member of the structurally complex mectin class of compounds. It is used to control insects in agriculture by acting through glutamate-gated chloride channels \[Gamma-aminobutyric acid (GABA) receptor\] and as an anthelmintic agent to treat common intestinal worms ([@c12]). Abamectin has evidence of population variability in response to pharmaceutical applications ([@c2]; [@c14]; [@c25]; [@c45]).

A novel SNP upstream of *sox7* was associated with GxE at a genome-wide significance level. There is strong evidence that this gene, a transcription factor, plays a critical role in development related to our Affected phenotype. Ablation of *Sox7* in mice leads to developmental delays, pericardial edema, and yolk sac defects ([@c51]). In zebrafish, *sox7* mutants have arterial block and pericardial edema after 72 hpf ([@c20]). Our functional validation experiments showed statistically significant suppression of *sox7* gene expression in Affected individuals vs. those Unaffected following chemical exposure. Although these expression differences were observed in a new, unbiased sample of individuals, there are likely more factors at play in diverting exposed individuals from normal development toward a severely abnormal phenotype. Additional experiments will be needed that probe key time points along the coordinated cascade of vertebrate developmental events ([@c55]). We present the current results as a step toward unraveling this etiology by highlighting promising genetic candidates for detailed study.

Further experimentation must be undertaken before we can completely unravel the causative etiology of genetic associations with differential susceptibility. Indeed, initial deep sequencing efforts indicated that the *sox7* SNP identified by our GWAS is highly correlated with nearby insertion/deletion variation. Thus, as with any genome-wide scan, the markers identified as significant highlight regions that, when considered in tandem with biological knowledge, are candidates for targeted follow-up. For example, the second SNP passing our significance threshold fell within the *erf* gene, for which there is evidence from other species for a plausible connection to our Affected phenotype. An *Erf* mutation in humans and mice is linked to craniosynostosis and related eye, snout, and jaw deformities ([@c57]).

In order to provide a clear test of whether our system could detect GxE related to differential population susceptibility, we implemented a straightforward approach of well-characterized genetic analysis tools. By focusing on the reduction of measurement error in phenotypes and having knowledge of an individual's entire exposure history, we augmented our statistical detection power. However, this does not discount the possibility that higher-order interactions between genetic factors (i.e., epistasis) are involved ([@c35]). Future work will include methods aimed at assessing this gene--gene interaction space ([@c56]).

Conclusions {#s5}
===========

Our approach leverages whole-organism, HTS data to introduce a data-driven strategy for identifying chemicals with putative GxE effects. This search for empirical patterns of differential response as an indicator of possible genetic explanations diverges from studies that aim to further characterize the small subset of chemicals with demonstrated GxE effects. Only with strong evidentiary support for differential population susceptibility do we assay the role of genetics in response to particular compounds. Moreover, such an unbiased approach may identify candidate GxE chemicals from a broader search space than traditionally studied, more accurately representing the diversity of real-world chemical space. In conclusion, by linking experimentation with bioinformatical prediction, we can make more informed choices on new experimental directions and avoid unnecessary expenditures of time and money-chasing effects that are unlikely to reflect genetic variation.
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=====================

###### 

Click here for additional data file.

The authors wish to thank the CGRB at Oregon State University for providing core support to conduct the sequencing studies. This work was supported by National Institutes of Health/National Institute of Environmental Health Sciences Grants U01 ES027294, P42 ES005948, P30 ES025128, P42 ES016465, 5T32 ES007329; U.S. Environmental Protection Agency (EPA) STAR Grants \#835168 and \#835796; and National Science Foundation Graduate Research Fellowship Grant No. DGE-1252376.
